argenx SE (ARGX): IPOs News

ARGX – Prices an upsized 5.865 mln share IPO at $17.00, slightly above the expected price of $16.62.


Key Facts Surrounding This News Item


  • ARGX had returned 0.00% year-to-date leading up to today’s news, versus a +5.96% return from the benchmark S&P 500 during the same period.

More Info About argenx SE (ARGX)


arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands. View our full ARGX ticker page with ratings, news, and more.

ARGX at a Glance

ARGX Current POWR Rating™
Overall POWR Rating™
ARGX Current Price $20.01 2.82%
More ARGX Ratings, Data, and News

ARGX Price Reaction

The day of this event (May. 18, 2017)
ARGX Closing Price$23.00 N/A%
ARGX Volume798,700
N/A% from avg
Leading up to this event
ARGX 1-mo returnN/A%
After this event
ARGX 1-day returnN/A%
ARGX 3-day returnN/A%
ARGX 5-day returnN/A%

ARGX Price Chart

More argenx SE (ARGX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ARGX News
Page generated in 3.0456 seconds.